Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002543
Status:
COMPLETED
Last Update Posted:
2013-07-18
First Post:
1999-11-01
Brief Title:
Gallium Nitrate in Treating Children With Brain Tumor Neuroblastoma Rhabdomyosarcoma Non-Hodgkins Lymphoma or Refractory Solid Tumors
Sponsor:
Medical College of Wisconsin
Organization:
National Cancer Institute NCI
Study Overview
Official Title:
GALLIUM NITRATE FOR THE TREATMENT OF MALIGNANT TUMORS A PHASE I STUDY
Status:
COMPLETED
Status Verified Date:
2007-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die
PURPOSE Phase I trial to study the effectiveness of gallium nitrate in young patients who have malignant brain tumors neuroblastoma rhabdomyosarcoma non-Hodgkins lymphoma or refractory solid tumor
PURPOSE Phase I trial to study the effectiveness of gallium nitrate in young patients who have malignant brain tumors neuroblastoma rhabdomyosarcoma non-Hodgkins lymphoma or refractory solid tumor
Detailed Description:
OBJECTIVES I Determine the safety and side effects of gallium nitrate GAN when used as an anticancer agent in pediatric patients with refractory solid tumors including malignant brain tumors neuroblastoma rhabdomyosarcoma and non-Hodgkins lymphoma II Evaluate these side effects in these patients
OUTLINE Single-Agent Chemotherapy Gallium Nitrate GAN NSC-15200
PROJECTED ACCRUAL At least 3 patients will be accrued at each dose studied
OUTLINE Single-Agent Chemotherapy Gallium Nitrate GAN NSC-15200
PROJECTED ACCRUAL At least 3 patients will be accrued at each dose studied
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-T93-0097D | Registry Identifier | PDQ Physician Data Query | None |
| CDR0000063244 | REGISTRY | None | None |
| CHW-9359 | None | None | None |